IL-13 in dermal type-2 dendritic cell specialization: From function to therapeutic targeting

Olivier Lamiable1, Maia Brewerton1,2, Franca Ronchese1

  • 1Malaghan Institute of Medical Research, Wellington, New Zealand.

Summary

This review explores how Interleukin-13 (IL-13) influences conventional dendritic cell (cDC) development in healthy skin and discusses potential impacts of IL-13 blocking therapies on skin immunity, particularly for atopic dermatitis.